BackNovo Nordisk A/S Class B Overview

Novo Nordisk A/S Class B Total Assets

Novo Nordisk A/S Class B's total assets is $590B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$594.94B
23.39% YoYΔ $112.79B vs prior year quarter

Peer trimmed avg / median

Loading

Novo Nordisk A/S Class B Total Assets History

Loading

Novo Nordisk A/S Class B vs. peers: Total Assets Comparison

Loading

Novo Nordisk A/S Class B Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Novo Nordisk A/S Class B (NONOF) FAQ

As of the most recent data (June 2026), NONOF shows a total assets of $590B. That compares with $480B in the prior-year period — up 23.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NONOF's total assets is now $590B (was $480B) — a 23.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Novo Nordisk A/S Class B is outperforming or lagging.

Tracking NONOF's total assets over time shows whether Novo Nordisk A/S Class B is scaling, shrinking, or reshaping that part of the business. The current reading is $590B That compares with $480B in the prior-year period — up 23.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Novo Nordisk A/S Class B's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $590B) with ownership activity and broader fundamentals.

Novo Nordisk A/S Class B's total assets is $590B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.